Hyloris Enrolls First Patient In Phase 3 Clinical Trial For

Hyloris Enrolls First Patient In Phase 3 Clinical Trial For Its Proprietary Mouth Rinse To Control Incidences Of Bleeding Related To Dental Procedures

Hyloris Enrolls First Patient In Phase 3 Clinical Trial For Its Proprietary Mouth Rinse To Control Incidences Of Bleeding Related To Dental Procedures

menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Belgium , United States , Jessica Mchargue , Jean Luc Vandebroek , Stijn Van Rompay , Nasdaq , Ibm , Hyloris Pharmaceuticals Sa Euronext Brussels , Investor Relations Communications , Linkedin , Truven Health Analytics , Hyloris Pharmaceuticals , Euronext Brussels , Tranexamic Acid Oral , Van Rompay , Chief Executive Officer , Tranexamic Acid Oral Rinse , Luc Vandebroek , Investor Relations , Health Analytics ,